Smart RI
Real World precision

The Challenge: The central challenge in diabetes diagnostics is the persistent gap between technological sophistication and global accessibility. While high-income regions are moving toward non-invasive wearables and AI-driven "Time in Range" metrics that offer a continuous view of metabolic health, much of the world still relies on infrequent, "snapshot" blood tests like the HbA1c or fasting glucose. These traditional methods often miss the early stages of the disease or fail to distinguish between different types of diabetes, such as Type 1 versus LADA, leading to dangerous misdiagnoses. Consequently, the field is currently defined by a race to develop low-cost, needle-free screening tools that can provide accurate, real-time data without the need for expensive laboratory infrastructure..

The Solution: Tailoring diagnostic reference ranges to an individual's specific biology—rather than using rigid "one-size-fits-all" thresholds—significantly reduces healthcare spending by eliminating unnecessary prescriptions and costly over-treatment. By utilizing precise metrics like Time in Range, clinicians can detect the earliest metabolic shifts, allowing for lifestyle interventions that prevent prediabetes from ever progressing to a full diagnosis. Ultimately, this precision-based approach shifts the financial burden away from treating expensive, chronic complications and toward proactive prevention, resulting in a healthier population and a more sustainable medical economy.